期刊文献+

CARD11与Bcl-2在弥漫性大B细胞淋巴瘤中的表达与意义 被引量:2

Study on the expression and signicance of CARD11 and Bcl-2 in diffuse large B-cell lymphoma
下载PDF
导出
摘要 目的观察弥漫性大B细胞淋巴瘤(diffuse large B-cell lymphoma)中CARD11与Bcl-2的表达情况,探讨它们在弥漫性大B细胞淋巴瘤中不同免疫分型中的表达及相互关系。方法选取弥漫性大B细胞淋巴瘤60例和反应性增生的淋巴结20例,采用组织芯片技术和免疫组织化学方法对弥漫性大B细胞淋巴瘤进行免疫分型并检测弥漫性大B细胞淋巴瘤免疫学类型GCB和ABC型中CARD11和Bcl-2表达情况。结果 (1)免疫分型60例弥漫性大B细胞淋巴瘤中免疫类型GCB25例,ABC35例。(2)60例弥漫性大B细胞淋巴瘤中免疫类型中CARD11与Bcl-2的表达情况:免疫类型GCB中CARD11的阳性率为24.0%,ABC中CARD11的阳性率为57.4%,两者之间P<0.05;GCB中Bcl-2的阳性率为32.0%,ABC中Bcl-2的阳性率为62.9%,两者之间P<0.05。结论①CARD11、NF-κB高表达与弥漫性大B细胞淋巴瘤的ABC类型相关。 Objective To study the expression and signicance of CARD11 and Bcl-2 in the common immunology types of diffuse large B-cell lymphoma and to explore the corrlativity during them.Methods 60 specimens of our diffuse large B-cell lymphoma patients and 20 specimens of reactive hyperplasia lymphoid node were selected,CARD11 and Bcl-2 were studied by using tissue chip technique and the immunohistochemical methods.Results(1)In 60 specimens of diffuse large B-cell lymphoma patients.immunology type:GCB 25 cases,ABC35 cases.(2)GCB 25 cases,the positive rates of CARD11 was 24.0%,ABC 35 cases,the positive rates of CARD11 was57.4%,there was significant difference between the two groups(P〈0.05);GCB 25 cases,the positive rates of Bcl-2 was 32.0%,ABC35 cases,the positive rates of Bcl-2 was 62.9%,there was significant difference between the two groups(P〈0.05).Conclusion The high expression of CARD11 and Bcl-2 were related to ABC immunology type of diffuse large B-cell lymphoma.
作者 左云海 刘勇
出处 《江西医药》 CAS 2011年第8期705-707,共3页 Jiangxi Medical Journal
关键词 弥漫性大B细胞淋巴瘤 BCL-2 CARD11 免疫组织化学 组织芯片 diffuse large B-cell lymphoma CARD11、Bcl-2 immunohiso-chemistry tissue chip
  • 相关文献

参考文献6

  • 1Coiffier B.Diffuse large B-cell lymphoma.Curropin Oncol,2001,13(5):325.
  • 2许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 3Hans CP,Denis D,Weisenburger,et al.Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue:microarry.Blood,2003,103(1):275.
  • 4Alizadeh AA,Eisen MB,Davis RE,et al.Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.Nature,2000,403 (6769):503.
  • 5Ngo VN,Davis RE,Lamy L,et al.A loss-of-function RNA interference screen for molecular targets in cancer.Nature,2006,441(7089):106.
  • 6黄忠连,顾康生,孟刚.Bcl-2与NF-κB/p65在弥漫性大B细胞淋巴瘤中的表达及意义[J].山东医药,2007,47(4):3-4. 被引量:10

二级参考文献7

  • 1赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 2谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 3Karin M,Cao Y,Greten FR,et al.NF-kappaB in cancer:from innocent bystander to major culprit[J].Nat Rev Cancer,20112,2(4);301-310.
  • 4Traeey L,Perez-Rosado A,Artiga MJ.Et al.Expression of the NF-kappaB targets BCL2 and BlRC5/Survivin characterizes smallB-cell and aggressive B-cell lymphomas,respectively[J].Jpathol,2005,206(2):123-134.
  • 5Alizadeh AA,Eisen MB,Davis RE,et al.Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling[J].Nature,2000,403(6769); 503-511.
  • 6Davis RE,Brown KD,Siebenlist U,et al.Constitutive nuclear factor kappaB activity is required for survival of activated B celllike diffuse large B cell lymphoma cells[J].J Exp Med,2001,194(12);1861-1874.
  • 7刘民培,陈伟,马世英,安天义,邹燕玲,初俊杰,吕振涛,张白洁,武宪荣.单克隆抗体SC13A的识别抗原在乳腺癌中的表达及其意义[J].癌症,1992,11(5):342-344. 被引量:1

共引文献1373

同被引文献6

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部